Thesis ID: CBB534271444

Trial and Error: The Invention of Cancer Chemotherapy 1950–1980 (2020)


Levy, Moran (Author)
Eyal, Gil (Advisor)

Columbia University
Eyal, Gil
Publication date: 2020
Language: English

Publication Date: 2020
Physical Details: 147

Between the mid-1940s and the mid-1970s oncology turned from a marginalized experimental field into one of the most dominant medical specialties in the United States. Cancer chemotherapy, once a controversial practice, became a standard therapy alongside surgery and radiation. The success of cancer chemotherapy, however, is not so simple to explain. Cancer chemotherapy was adopted despite broad and evident dissatisfaction with its limited clinical achievements, common among patients and doctors alike. To explain the success of cancer chemotherapy, this dissertation examines the social processes that allowed for the emergence and stabilization of a new therapeutic field. I show that common sociological approaches for studying medical experts, such as the sociology of the professions and medicalization theories, fail to provide a convincing explanation for the emergence of chemotherapy because they assume the existence of professional entities or a set of tasks and problems as pre-given facts. Alternatively, I build on these approaches to show that oncology itself, as well as the tasks and problems of cancer medicine, evolved with the invention of the new therapeutic technologies of cancer chemotherapy. I argue that when cancer chemotherapists, a nascent professional group, failed to deliver on their promise for a cancer cure in the 1940s, they began exploring what cancer chemotherapy might become. During the following decades, they gradually reinvented the diagnostic categories, clinical methods and therapeutic objectives of oncology, thus establishing a new mode of therapeutic intervention. The dissertation further examines the tactics and resources that contributed to the success of these efforts and to the stabilization of the new therapy. I trace how oncologists leveraged limited clinical achievements to (a) legitimate their practices and frame experimental outcomes as therapeutic objectives and (b) assemble the infrastructure and alliances needed to expand the enterprise and improve on existing clinical practices and results. The first paper ‘Adequate Trials: How the Search for a Cure Shaped Leukemia Diagnosis?’ addresses the rewriting of the diagnosis of leukemia, to demonstrate that the success of chemotherapy depended on the ability to transform the categories used to classify cancers and patients. Mobilizing bureaucratic capacities and redefining their ethical commitments, oncologists managed to allocate the ‘right patients’ to the ‘right trials,’ reshuffling existing diagnostic classifications, so that the conditions under which drugs could ‘work’ might be created. The second paper ‘From Bullets to Cocktails: The Invention of New Therapeutic Methods in Cancer Chemotherapy’ explains how oncologists sheltered themselves from the external demands of patients and regulators to secure space for experimentation with controversial procedures of combination therapy. The paper traces the epistemic, institutional and ethical resources mobilized by oncologists to articulate their research agendas as problems for basic science, thus establishing alliances within the National Institute of Health. The third paper, ‘How Means Turn to Ends: A Pragmatist Account of the Rise of Oncology’ addresses the normative legitimation of the objectives of chemotherapy to demonstrate that the framing of new experimental categories in terms of community-based clinical care was a key to the success of oncology. Together, the three papers demonstrate that to make medical drugs ‘work’ (i.e., produce predictable effects that are commonly seen as therapeutically valuable), oncologists had to restructure the practices, institutions, classifications, objectives, and roles in cancer research and clinical care. The dissertation thus suggests that an analytical focus on the invention of new modes of therapeutic intervention would provide valuable insights into questions central to a wide range of sociological investigations. The invention of therapeutic technologies offers a lens for exploring the transformation of the institutions and practices of the medical profession, biomedical research, drug regulation and healthcare.

Citation URI

This citation is part of the Isis database.

Similar Citations

Chapter Julie Livingston; (2016)
Chemotherapy in the Shadow of Antiretrovirals: The Ambiguities of Hope as Seen in an African Cancer Ward (/p/isis/citation/CBB577811847/) unapi

Book Keating, Peter; Cambrosio, Alberto; (2012)
Cancer on Trial: Oncology as a New Style of Practice (/p/isis/citation/CBB001250375/) unapi

Article Slater, Leo B.; (2006)
Chemists and National Emergency: NIH's Unit of Chemotherapy during World War II (/p/isis/citation/CBB000741588/) unapi

Article Sharma, Padmanee; Allison, James P.; (2012)
Lloyd J. Old (1933--2011) (/p/isis/citation/CBB001320473/) unapi

Book Johnstone, Emm Barnes; (2015)
The Changing Faces of Childhood Cancer: Clinical and Cultural Visions since 1940 (/p/isis/citation/CBB001510021/) unapi

Article Nikos Giatrakos; Nikos Katzouris; Antonios Deligiannakis; Alexander Artikis; Minos Garofalakis; George Paliouras; Holger Arndt; Raffaele Grasso; Ralf Klinkenberg; Miguel Ponce De Leon; Gian Gaetano Tartaglia; Alfonso Valencia; Dimitrios Zissis; (June 2019)
Interactive Extreme-Scale Analytics: Towards Battling Cancer (/p/isis/citation/CBB319384817/) unapi

Book Hannah Dudley-Shotwell; (2020)
Revolutionizing Women's Healthcare: The Feminist Self-Help Movement in America (/p/isis/citation/CBB446855800/) unapi

Book Engel, Jonathan; (2006)
Poor People's Medicine: Medicaid and American Charity Care since 1965 (/p/isis/citation/CBB000930561/) unapi

Book Hoyt, Kendall; (2012)
Long Shot: Vaccines for National Defense (/p/isis/citation/CBB001210034/) unapi

Book Nancy D. Campbell; (2020)
OD: Naloxone and the Politics of Overdose (/p/isis/citation/CBB601007525/) unapi

Book Emma Bedor Hiland; (2021)
Therapy Tech: The Digital Transformation of Mental Healthcare (/p/isis/citation/CBB444822952/) unapi

Book Weinstein, Deborah; (2013)
The Pathological Family: Postwar America and the Rise of Family Therapy (/p/isis/citation/CBB001201271/) unapi

Book David Clark; (2016)
To Comfort Always: A history of palliative medicine since the nineteenth century (/p/isis/citation/CBB432012178/) unapi

Article Linker, Beth; (2013)
On the Borderland of Medical and Disability History: A Survey of the Fields (/p/isis/citation/CBB001214256/) unapi

Book Livingston, Julie; (2012)
Improvising Medicine: An African Oncology Ward in an Emerging Cancer Epidemic (/p/isis/citation/CBB001420179/) unapi

Article Jacalyn Duffin; (2020)
The Yew Tree and the Crab: A Case Study of Big Pharma, Small Pharma, and an Anti-Cancer Drug (/p/isis/citation/CBB756855341/) unapi

Article Jennifer Fraser; (2020)
Rendering Inuit cancer “visible”: Geography, pathology, and nosology in Arctic cancer research (/p/isis/citation/CBB087829229/) unapi

Authors & Contributors
Livingston, Julie
Allison, James P.
Buschini, José D.
Cambrosio, Alberto
Campbell, Nancy D.
Cantor, David
Bulletin for the History of Chemistry
Bulletin of the History of Medicine
Canadian Bulletin of Medical History/Bulletin Canadienne d'Histoire de la Medecine
História, Ciências, Saúde---Manguinhos
IEEE Technology and Society Magazine
Medical History
Duke University Press
Cornell University Press
Harvard University Press
MIT Press
Oxford University Press
Palgrave Macmillan
Therapeutic practice; therapy; treatment
Cancer; tumors
Medicine and society
Health care
Public health
Gori, Gio Batta
Old, Lloyd J.
Time Periods
20th century, late
21st century
20th century
19th century
20th century, early
United States
Great Britain
Massachusetts (U.S.)
New Mexico (U.S.)
National Cancer Institute (U.S.)
National Institute of Health (U.S.)

Be the first to comment!

{{ comment.created_by.username }} on {{ comment.created_on | date:'medium' }}

Log in or register to comment